Company / Gross Profit
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Gross Profit History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit
$45.8M
FY2025
5-year range
$37.3M / $58.9M
FY2021-FY2025
Trend
+22.8%
vs FY2024
Sector context
#98 of 100
Health Care
What the data says
Among 100 Health Care companies, PACIFIC BIOSCIENCES OF CALIFORNIA, INC. is in the bottom 2% for gross profit. Gross Profit has fluctuated over the past 10 years, ranging from $25M in FY2018 to $59M in FY2021.
Based on SEC 10-K filings.
$46M in FY2025 with a 5-year CAGR of +7.0%.
Declined from $53M to $46M over the past 2 years.
Health Care sector context is included.
Gross Profit over time
Growth rates
- 3-Year CAGR
- -2.3%
- 5-Year CAGR
- +7.0%
- 10-Year CAGR
- -
Sector benchmark
Bottom 2% in Health CareTop 98% of 100This company $45.8M Sector average $1.8B
▼
-97.5% below sector average
Key checks
Key Insights
- 5-year CAGR of +7.0%, indicating consistent growth.
- In FY2025, gross profit increased 22.8% year-over-year.
- Ranks #98 out of 100 companies in the Health Care sector.
- Peak gross profit was recorded in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -1.92 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross ProfitValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $45.8M | +22.8% |
| FY2024 | $37.3M | -29.4% |
| FY2023 | $52.8M | +7.6% |
| FY2022 | $49.0M | -16.7% |
| FY2021 | $58.9M | +80.7% |
| FY2020 | $32.6M | -5.8% |
| FY2019 | $34.6M | +37.8% |
| FY2018 | $25.1M | -27.6% |
| FY2017 | $34.7M | -21.5% |
| FY2016 | $44.2M | +588.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026